![](https://www.biopharmservices.com/wp-content/uploads/2021/07/PR-CPI-Image01-Credits-550x350.jpg)
UK biomanufacturing team to spearhead development of advanced controls to accelerate drug and vaccine manufacturing
A UK-based consortium consisting of BiologIC Technologies, Biopharm Services, CPI, Pall Corporation, and SCIEX has announced the launch of a project that aims to develop automated manufacturing controls for use in the manufacture of biologics. The project, worth a total of £3.1million, including equipment contributions,